SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-254574
Filing Date
2017-08-10
Accepted
2017-08-10 16:45:33
Documents
3
Period of Report
2017-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d441068d8k.htm 8-K 16313
2 EX-99.1 d441068dex991.htm EX-99.1 58348
3 GRAPHIC g441068img3.jpg GRAPHIC 5478
  Complete submission text file 0001193125-17-254574.txt   83340
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 171022009
SIC: 2836 Biological Products, (No Diagnostic Substances)